NCI Update! NO.14 New Cosmetic Ingredient has now been approved by China's NMPA!


The NO.14 New Cosmetic Ingredient(NCI) "Amidinobenzyl Benzylsulfonyl D-Seryl Homophenylalaninamide Acetate" has now been approved by NMPA in China!

ZMUni searched the database query on the Chinese National Medical Products Administration (NMPA) official platform which shows that the Notifier/Filing person (Brand Owner) "DSM Vitamins (Shanghai) Co., Ltd." has successfully passed the NMPA notification review of the New Cosmetic Ingredient "Amidinobenzyl Benzylsulfonyl D-Seryl Homophenylalaninamide Acetate"!

As an example, the published Chinese NCI notifying/filing number is "国妆原备字20220014" on the NMPA platform, the approved date is July 5, 2022.

 

[The “ID” information of NO.14 New Cosmetic Ingredient]

English name: Amidinobenzyl Benzylsulfonyl D-Seryl Homophenylalaninamide Acetate

Chinese name: 苄基磺酰基D-丝氨酰基高苯丙氨酸脒基苄胺乙酸盐

Purpose of use: Skin protector, Moisturizer

Use or application scope: Used in various skincare cosmetics(include leave-on and rinse-off cosmetics)

Safe use amount: 0.001%(This use amount is calculated based on the recommended use amount 1% of the marketed product SYN-UP® of this ingredient. Meanwhile, in accordance with regulatory requirements, the “safe use amount” under the notification condition of this ingredient shall not be higher than the use amount in cosmetics marketed outside mainland China. Therefore, this “safe use amount” is not the result based on safe evaluation, and not the highest limited amount for safe use of this ingredient)

(maximum allowable concentration in use of cosmetics)

 

———————————

ZMUni Chinese Cosmetic Regulation Compliance Centre 中贸合规中心

Contact us: info@zmuni.com

Post a Comment

0 Comments